[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556055":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":19,"responsibleParty":36,"collaborators":10,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"University of Roma La Sapienza","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"patients underwent surgery for secreting adrenal lesion",null,{"label":12,"type":10,"description":10,"interventionNames":10},"patients underwent surgery for non- secreting adrenal lesion",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Diletta D Corallino","CONTACT","+39-3888592412","diletta.corallino1989@gmail.com",[20],{"facility":21,"status":22,"city":23,"state":24,"zip":10,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"General and Mininvasive Surgery Department, Pederzoli Hospital,","RECRUITING","Peschiera del Garda","Verona, Italy.","Italy","IT",{"type":28,"coordinates":29},"Point",[30,31],10.68614,45.43912,{"lat":31,"lon":30},[34],{"name":35,"role":16,"phone":10,"phoneExt":10,"email":10},"Marco Inama",{"type":37,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":40,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Diletta Corallino","Principal Investigator; M.D; PhD student","IRCCS San Raffaele","100556055","crisal-studycancer-risk-in-secreting-adrenal-lesions-100556055",false,"NCT06520111","CRISAL Study:Cancer Risk In Secreting Adrenal Lesions","CRISAL","Inclusion Criteria:\n\n* Patients undergoing elective adrenalectomy;\n* Patients aged ≥ 18 years\n* Acceptance of informed consent\n\nExclusion Criteria:\n\nPatients undergoing emergency adrenalectomy;\n\n* Patients aged ≤ 18 years\n* Pregnant patients","ALL","18 Years",{"count":51,"type":52},300,"ESTIMATED","12 Months","OBSERVATIONAL","The aim of the present study is to report the cancer risk in secreting adrenal lesions. Secondary aims: to compare the incidence of cancer in secreting versus non-secreting adrenal lesions, in order to evaluate whether adrenal hormone activity can be considered an independent predictive indicator of malignancy; compare intraoperative and 30-day postoperative outcomes of patients undergoing adrenalectomy for secreting adrenal lesions versus non-secretoring lesions; regardless of the type of adrenal lesion, identify if there is one MIS adrenal approach that is superior to the others in terms of intra- and postoperative outcomes.",[57,58,59],"Adrenal Tumor","Adrenal Incidentaloma","Surgery",[61,62,63],"cancer risk","adrenal surgery","secreting adrenal lesions","2024-08-27",{"date":66,"type":67},"2024-08-30","ACTUAL",{"date":64,"type":52},{"date":70,"type":52},"2024-11-10",{"name":5,"class":6},1]